Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11504385
Proteolysis targeting chimeric molecule, preparation method, and application
granted -
US 11503999
Hyperspectral imaging for detection of Alzheimer's disease
granted -
US 11505782
Cell-based vehicles for potentiation of viral therapy
granted -
US 11505601
Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum
granted -
US 11505604
Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer
granted -
US 11505598
Antibodies to botulinum neurotoxins
granted -
US 11505575
Cyclic polypeptides for PCSK9 inhibition
granted -
US 11505591
T-cell modulatory multimeric polypeptides and methods of use thereof
granted -
US 11505588
T-cell modulatory multimeric polypeptides and methods of use thereof
granted -
US 11504427
Acoustic and ultrasound-based mechanogenetics and thermogenetics for immunotherapy
granted -
US 11505551
Methods for preparing substituted pyridinone-containing tricyclic compounds
granted -
US 11505525
Branched discrete PEG constructs
granted -
US 11504429
Pharmaceutical compositions comprising meloxicam
granted -
US 11505572
Therapeutics for the treatment of glaucoma
granted -
US 11504394
Targeted ionophore-based metal delivery
granted -
US 11504403
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
granted -
US 11504391
Modified RNA agents with reduced off-target effect
granted -
US 11504390
Treatment of increased lipid levels with sterol regulatory element binding transcription factor 1 (SREBF1) inhibitors
granted -
US 11504346
Redox-activated pro-chelators
granted -
US 11504364
Inhibitors of fibroblast activation protein
granted -
US 11504389
Tau modulators and methods and compositions for delivery thereof
granted -
US 11505593
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11504402
Compositions comprising bacterially derived minicells and methods of using the same
granted -
US 11505594
Anti-VEGF protein compositions and methods for producing the same
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.